A novel region of deletion on chromosome 6q23.3 spanning less than 500 Kb in high grade invasive epithelial ovarian cancer

Oncogene

Volumn 18, Issue 26, 1999, Pages 3913-3918

  Shridhar, Viji ^a,b   Staub, Julie ^a   Huntley, Brenda ^a   Cliby, William ^a   Jenkins, Robert ^a   Pass, Harvey I ^b   Hartmann, Lynn ^a   Smith, David I ^a  

^a MAYO CLINIC   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

6q23.3 loss; Invasive epithelial ovarian cancer; Tumor suppressor

Indexed keywords

ALLELE; ARTICLE; CHROMOSOME 6Q; CHROMOSOME DELETION; CHROMOSOME LOSS; CHROMOSOME MAP; FEMALE; OVARY CANCER; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CHROMOSOME FRAGILITY; CHROMOSOMES, HUMAN, PAIR 6; FEMALE; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; SEQUENCE DELETION;

EID: 0033166650     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202756     Document Type: Article

References (35)

1. Abdollahi A, Roberts D, Godwin AK, Schultz DC, Sonoda G, Testa JR and Hamilton TC. (1997). Oncogene, 14, 1973-1979.
2. Banga SS, Kim S, Hubbard K, Dasgupta T, Jha KK, Kraemer P and Ozer HL. (1997). Oncogene, 14, 313-321.
3. Bell DW, Jhanwar SC and Testa JR. (1997). Cancer Res., 57, 4057-4062.
4. Cannistra SA. (1993). N. Engl. J. Med., 329, 1550-1559.
5. Chappell SA, Walsh T, Walker RA and Shaw JA. (1997). Br. J. Cancer, 75, 1324-1329.
6. Church SL, Grant JW, Ridnour LA, Oberley LW, Swanson PE, Meltzer PS, Trent JM (1993). Proc. Natl. Acad. Sci. USA, 90, 3113-3117.
7. Cliby W, Ritland S, Hartmann L, Dodson M, Halling KC, Keeney G, Podratz KC and Jenkins RB. (1993). Cancer Res., 53, 2393-2398.
8. Colitti CV, Rodabaugh KJ, Welch WR, Berkowitz RS and Mok SC. (1998). Oncogcne, 16, 555-559.
9. Collins A, Frezal J, Teague J and Morton NE. (1996). Proc. Natl. Acad. Sci. USA, 93, 14771-14775.
10. Cooke IE, Shelling AN, Meuth VG, Charnock ML and Ganesan TS. (1996). Genes Chromosom. Cancer, 15, 223-233.
11. Cooney KA, Wetzel JC, Consolino CM and Wanjo KJ. (1996). Cancer Res., 56, 4150-4156.
12. Dodson MK, Hartmann LC, Cliby WA, DeLacey KA, Keeney GL, Ritland SR, Su JQ, Podratz KC and Jenkins RB. (1993). Cancer Res., 53, 4456-4460.
13. Foulkes WD, Ragoussis J, Stamp GW, Allan GJ and Trowsdale J. (1993). Br. J. Cancer, 67, 551-559.
14. Guan XY, Horsman D, Zhang HE, Parsa NZ, Meltzer PS and Trent JM. (1996). Blood, 88, 1418-1422.
15. Hauptschein RS, Gamberi B, Rao PH, Frigeri F, Scotto L, Venkatraj VS, Gaidano G, Rutner T, Edwards YH, Chaganti RS and Dalla-Favera R. (1998). Genomics, 50, 170-186.
16. Henderson BE, Ross RK and Pike MC. (1991). Science, 254, 1131-1138.
17. Jiang X, Hitchcock A, Bryan EJ, Watson RH, Englefield P, Thomas EJ and Campbell IG. (1996). Cancer Res., 56, 3534-3539.
18. Landis SH, Murray T, Bolden S and Wingo PA. (1998). Cancer J. Clin., 48, 6-29.
19. Leary JA, Doris CP, Boltz EM, Houghton CRS, Kefford RF and Friedlander ML. (1993). Int. J. Gynecol. Cancer, 3, 293-298.
20. Lee JH, Kavanagh JJ, Wildrick DM, Wharton JT, Blick M. (1990). Cancer Res., 50, 2724-2728.
21. Morelli C, Sherratt T, Trabanelli C, Rimessi P, Gualandi F, Greaves MJ, Negrini M, Boyle JM and Barbanti-Brodano G. (1997). Cancer Res., 57, 4152-4157.
22. Orphanos V, McGown G, Hey Y, Thorncroft M, Santibanez-Koref M, Russell SE, Hickey I, Atkinson RJ and Boyle JM. (1995). Br. J. Cancer, 71, 666-669.
23. Quimado L, Seruca R, Costa-Periera A and Castedo S. (1995). Genes Chromosom. Cancer, 14, 28-34.
24. Rodabaugh KJ, Blanchard G, Welch WR, Bell DA, Berkowitz RS, Mok SC. (1995). Cancer Res., 55, 2169-2172.
25. Saito S, Saito H, Koi S, Sague S, Kudo R, Saito J, Noda K and Nakamura Y. (1992). Cancer Res., 52, 5815-5817.
26. Saito S, Sirahama S, Matsushima M, Susuki M, Sagae S, Kudo R, Saito J, Noda K and Nakamura Y. (1996). Cancer Res., 56, 5586-5589.
27. Sandhu AK, Hubbard K, Kau GP, Jha KK, Ozer HL and Athwal RS. (1994). Proc. Natl. Acad. Sci, USA, 91, 5498-5502.
28. Sheng SM, Marchetti A, Buttitta F, Champerne MH, Campani D, Bistocchi M, Lidereau R and Callahan R. (1996). Br. J. Cancer, 73, 144-147.
29. Shridhar R, Shridhar V, Wang X, Paradee W, Dugan M, Sarkar F, Wilke C, Glover TW, Vaitkevicius V and Smith DI. (1996). Cancer Res., 56, 4347-4350.
30. Shridhar V, Siegfried J, Hunt J, Maria del Mar A and Smith DI. (1994). Cancer Res., 54, 2084-2087.
31. Shridhar V, Wang L, Rosati R, Paradee W, Shridhar R, Mullins C, Sakr W, Grignon G, Miller OJ, Qi C Sun Petros J and Smith DI. (1997). Oncogene, 20, 1269-1277.
32. Theile M, Seitz S, Arnold W, Jandrig B, Frege R, Schlag PM, Haensch W, Guski H, Winzer KJ, Barrett JC and Scherneck S. (1996). Oncogene, 13, 677-685.
33. Tibiletti MG, Trubia M, Ponti E, Sessa L, Acquati F, Furlan D, Bernasconi B, Fichera M, Mihalich A, Ziegler A, Volz A, Facco C, Riva C, Cremonesi L, Ferrari M and Taramelli R. (1998). Oncogene, 16, 1639-1642.
34. Walker GJ, Palmer JM, Walters MK, Nancarrow DJ, Parsons PJ and Hayward NK. (1994). Int. J. Cancer, 58, 203-206.
35. Wang ND, Testa JR and Smith DI. (1993). Genomics, 17, 341-347.